Passive Anti-amyloid Beta Monoclonal Antibodies: Lessons Learned over Past 20 Years
Abstract Alzheimer’s disease (AD) is a neurodegenerative disorder that significantly impairs cognitive and functional abilities, placing a substantial burden on both patients and caregivers. Current symptomatic treatments fail to halt the progression of AD, highlighting the urgent need for more effe...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2024-10-01
|
Series: | Neurology and Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1007/s40120-024-00664-z |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|